On the basis of test type, the HPV testing and Pap test market has been divided into two major segments, namely, HPV testing and Pap test. The HPV testing segment is further classified into three sub-segments, namely, follow-up HPV testing, co-testing, HPV primary testing. The Pap test segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. But this segment is projected to decline at a negative CAGR during the forecast period due to due the shift towards the use of HPV testing, as it provides enhanced accuracy and sensitivity than Pap test. Furthermore, the HPV testing segment is expected to grow at the highest CAGR in the next five years, owing to increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.
On the basis of type of application, the global HPV testing and Pap test market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.
On the basis of type of end user, the HPV testing and Pap test market is classified into three segments, namely, hospitals, laboratories, physicians’ offices and clinics. The laboratories end-user segment is expected account for the largest share of the HPV testing and Pap test market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2015, the HPV testing and Pap test market is expected to be dominated by North America and expected to grow at highest CAGR during forecast period. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing and Pap test market in the North American region.
